RXRX logo

RXRX
Recursion Pharmaceuticals Inc

14,626
Mkt Cap
$1.91B
Volume
14.61M
52W High
$7.89
52W Low
$2.98
PE Ratio
-2.47
RXRX Fundamentals
Price
$3.67
Prev Close
$3.77
Open
$3.65
50D MA
$4.20
Beta
2.67
Avg. Volume
20.64M
EPS (Annual)
-$1.44
P/B
1.71
Rev/Employee
$124,468.33
$1,160.13
Loading...
Loading...

About

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
600

Frequently Asked Questions

What is Market Cap of Recursion Pharmaceuticals Inc - Ordinary Shares - Class A?
What is the 52-week high for Recursion Pharmaceuticals Inc - Ordinary Shares - Class A?
What is the 52-week low for Recursion Pharmaceuticals Inc - Ordinary Shares - Class A?
What is Recursion Pharmaceuticals Inc - Ordinary Shares - Class A stock price today?
What was Recursion Pharmaceuticals Inc - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Recursion Pharmaceuticals Inc - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Recursion Pharmaceuticals Inc - Ordinary Shares - Class A?
What is the 50-day moving average of Recursion Pharmaceuticals Inc - Ordinary Shares - Class A?
How many employees does Recursion Pharmaceuticals Inc - Ordinary Shares - Class A have?

Latest RXRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.